Bio-Rad Laboratories (BIO-B) Long-Term Investments (2012 - 2026)

Bio-Rad Laboratories (BIO-B) has 15 years of Long-Term Investments data on file, last reported at $5.3 billion in Q1 2026.

• Long-Term Investments for Q1 2026 came in at $5.3 billion, up 6.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.3 billion (up 6.36% YoY), and the FY2025 annual result was $6.1 billion, up 26.13% from the prior year.
• Long-Term Investments fell to $5.3 billion in Q1 2026 per BIO-B's latest filing, from $6.1 billion in the prior quarter.
• Over five years, Long-Term Investments peaked at $9.7 billion in Q1 2022 and troughed at $4.8 billion in Q4 2024.
• A 5-year average of $6.8 billion and a median of $7.2 billion in 2023 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2022 and 2025: Long-Term Investments plunged 54.04% in 2022, then advanced 26.13% in 2025.
• A 5-year view of Long-Term Investments shows it stood at $8.8 billion in 2022, then declined by 12.83% to $7.7 billion in 2023, then tumbled by 37.14% to $4.8 billion in 2024, then advanced by 26.13% to $6.1 billion in 2025, then dropped by 12.97% to $5.3 billion in 2026.
• Business Quant data shows BIO-B's Long-Term Investments at $5.3 billion in Q1 2026, $6.1 billion in Q4 2025, and $5.1 billion in Q3 2025.